Stress accelerates the growth of certain types of tumors. Here we report a possible metabolic mechanism underlying this phenomenon. Some early features of transformation include increased number of glucose transporters and greatly enhanced rates of glucose uptake; this adaptation accommodates the vast energy demands needed for neoplastic growth. In contrast, glucocorticoids, a class of steroid hormones secreted during stress, inhibit glucose transport in various tissues; this is one route by which circulating glucose concentrations are raised during stress. We reasoned that should transformed cells become resistant to this inhibitory action of glucocorticoids, such cells would gain preferential access to these elevated concentrations of glucose. In agreement with this, we observed that Fujinami sarcoma virustransformed fibroblasts became resistant to this glucocorticoid action both in vitro and in the rat. As a result, under conditions where glucocorticoids exerted catabolic effects upon nontransformed fibroblasts (inhibition of metabolism and ATP concentrations), the opposite occurred in the virally transformed cells. We observe that this glucocorticoid resistance upon transformation cannot be explained by depletion of glucocorticoid receptors; previous studies have suggested that transformation causes an alteration in trafficking of such receptors. Because of this resistance of transformed fibroblasts to the inhibitory effects of glucocorticoids upon glucose transport, glucose stores throughout the body are, in effect, preferentially shunted to such tumors during stress.
A characteristic of a certain subset of tumors, particularly virally induced ones, is their ability to grow faster in animals undergoing either somatic or psychogenic stress (1) (2) (3) (4) (5) . Stress can be immunosuppressive through a variety of humoral and neural mechanisms (6, 7) , and it has often been theorized that stress-induced acceleration of tumor growth is a result of such immunosuppression (2, 4) . However, the mechanistic links between such immunosuppression and accelerated tumor growth remain quite speculative. Here we demonstrate a possible mechanism by which stress accelerates growth in one type of virally induced tumor. Accelerated growth may derive from the metabolic consequences of stress in addition to any speculated immunological consequences.
One of the best characterized physiological reactions to stress is the release of glucocorticoids, a class of steroid hormones, from the adrenal. Glucocorticoids decrease glucose uptake in many peripheral tissues (8) , both by sequestering glucose transporters to intracellular storage sites (9, 10) and by decreasing transporter transcription (11) . The result of this and other glucocorticoid actions (e.g., enhanced gluconeogenesis) is increased circulating glucose.
In contrast, a characteristic change in transformed cells is a 5-to 7-fold increase in glucose uptake and utilization (12) (13) (14) . This results from a 5-to 10-fold increase in transcription of the glucose transporter gene (15, 16) , producing an equivalent increase in numbers of functional transporters at the cell surface (17) . This genomic event is one of the earliest following transformation and is thought to accommodate the vast energy demands needed for neoplastic growth (15, 16 (5) .
MATERIALS AND METHODS
Cell Transformation and Tumor Growth. Studies were performed on wild-type rat fibroblasts (3Y1, American Type Culture Collection) and on fibroblasts that were stably transformed with FSV or a temperature-sensitive FSV strain (ts225). Subcutaneous tumors were grown by injecting 1.5-2.0 x 107 FSV-transformed fibroblasts into 300-g male SpragueDawley rats. After 2 weeks the cells formed unicentric nonproductive 5-to 10-g tumors at the site of injection.
In Vitro dGlc Uptake. Cells were grown in Dulbecco's modified Eagle's medium (5.5 mM D-glucose) containing 5% fetal bovine serum, L-glutamine (2 mM), streptomycin sulfate (100 ug/ml), and penicillin G (100 units/ml, GIBCO) in a humidified CO2 incubator at 370C. Some ts225 cells were maintained at the permissive temperature, 32°C. Cells were washed twice with Krebs-Ringer phosphate buffer containing amino acids and vitamins (GIBCO), L-glutamine (2 mM), D-glucose (5.5 mM), streptomycin, and penicillin at pH 7.4 (KRPB/Glc) and incubated with or without 100 nM dexamethasone for 5 hr at 37°C or 32°C. Cells were washed twice with glucose-free KRPB (37°C or 32°C), and after 10 min of equilibration, sugar uptake was initiated by adding 1 (19) . One group of rats was adrenalectomized the next day and maintained on 0.9% NaCl. Another, nonadrenalectomized group was administered the species-typical glucocorticoid of rats, corticosterone (5 mg/day, given subcutaneously in 1 ml of peanut oil). Such a treatment produces sustained increases in circulating corticosterone concentrations to the range seen during major stressors (20 (Fig.  1A) . Dexamethasone (a synthetic glucocorticoid) decreased dGlc transport in both untransformed fibroblasts (3Y1 cells) and transformed fibroblasts (FSV cells; P < 0.001); however, the magnitude of the effect was significantly smaller in the FSV cells (P < 0.001; Fig. 1C ). We also examined cells transformed with a temperature-sensitive FSV mutant, which show the transformed phenotype at 320C. Transformation was again associated with enhanced dGlc uptake (Fig.  1B) . Dexamethasone decreased dGlc uptake at the nonpermissive temperature (P < 0.001), but not at the permissive temperature (Fig. 1D ).
This effect also occurred in the whole animal.
[14C]dGlc uptake in FSV-derived tumors was greatly enhanced in glucocorticoid-free rats relative to other tissues ( Fig. 2A) . Glucocorticoids decreased dGlc uptake 35-50% in nontransformed tissues but failed to inhibit dGlc uptake in the FSV-derived tumor (Fig. 2B) .
Thus Ears Sm M bolic rate increased with increasing glucose availability in both 3Y1 cells and FSV-transformed cells (P < 0.001 and 0.005, respectively) (Fig. 4) . Moreover, transformed cells had markedly higher metabolic rates than nontransformed cells (e.g., a >4.5-fold higher rate at 5 mM glucose). This is consonant with the enhanced glucose uptake and utilization seen in transformed cells (Figs. 1 and 2 ). In addition, higher metabolic demands are a likely explanation for their decreased stores of ATP (Fig. 3) . Corticosterone exposure decreased metabolism in 3Y1 cells (P < 0.001), but not in FSV-transformed cells (P < 0.44, Fig. 4 ).
DISCUSSION
Stress can accelerate the growth of certain tumors, particularly those that are virally derived (1) (2) (3) (4) (5) (A) dGlc uptake was greatly enhanced in tumor tissues relative to nontransformed tissues in the adrenalectomized rats. Uptake by tumor was taken as 100%. (B) Corticosterone did not affect dGlc uptake by the FSV tumor but inhibited uptake in all other tissues. Fat was taken from a fat pad inside the abdominal cavity. Ears provided a nontransformed source of fibroblasts. Smooth muscle (Sm M) was taken from the stomach wall, and skeletal muscle (Sk M) came from the leg. *, P < 0.05; **, P < 0.02 for comparisons of corticosterone-treated animals (n = 10) with adrenalectomized controls (n = 13) for each tissue type. (5), direct glucocorticoid induction of proviral transcription (3) , stress-induced opioid inhibition of immunity (3) , and the effects of stress upon diet (4) . The (26) and are more readily redistributed to the cytosolic compartment in an inactivated form (26, 27) . As a result, gene transcription in virally transformed cells becomes relatively glucocorticoid insensitive (28, 29) . Gluco 
